Literature DB >> 588647

Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke.

R G Robinson, F E Bloom.   

Abstract

Middle cerebral artery ligation in the rat produces decreases in catecholamine concentrations at brain sites uninjured by ischemic damage and a transient increase in spontaneous horizontal activity. Development of this hyperactivity can be blocked by postoperative treatment with the antidepressant, desmethylimipramine, or by preoperative destruction of norepinephrine terminals with 6-hydroxydopamine. These results suggest that ischemic damage to the cerebral cortex which injures some axonal branches of elaborately arborizing catecholamine-containing neurons may alter the biochemical and functional state of the entire system in its intact collateral axons. Thus the concept of stroke as a local injury producing symptoms by local structure-function relationships is conceptually inadequate, and poststroke symptoms must be evaluated with these "whole brain" concepts in mind. We suggest that the poststroke symptoms of apathy and depression may represent emotional changes which result from pathophysiological processes in catecholamine neurons far from the site of the stroke.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588647

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

Review 1.  The neuroanatomical model of post-stroke depression: towards a change of focus?

Authors:  Micaela Santos; Enikö Kövari; Gabriel Gold; Vasilis P Bozikas; Patrick R Hof; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  J Neurol Sci       Date:  2009-03-04       Impact factor: 3.181

Review 2.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

Review 3.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

4.  A model for the study of stroke using the rat. Surgical ligation of the middle cerebral artery in the rat.

Authors:  R G Robinson
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

5.  Effects of Duloxetine on Urethral Continence Reflex and Bladder Activity in Rats with Cerebral Infarction.

Authors:  Minoru Miyazato; Takeya Kitta; Yasuhiro Kaiho; Takuma Oshiro; Seiichi Saito; Michael B Chancellor; William C de Groat; Naoki Yoshimura
Journal:  J Urol       Date:  2015-03-21       Impact factor: 7.450

Review 6.  Natural Products for the Treatment of Post-stroke Depression.

Authors:  Chaoyou Fang; Zeyu Zhang; Houshi Xu; Yibo Liu; Xiaoyu Wang; Ling Yuan; Yuanzhi Xu; Zhengyang Zhu; Anke Zhang; Anwen Shao; Meiqing Lou
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

Review 7.  Stress as necessary component of realistic recovery in animal models of experimental stroke.

Authors:  Frederick R Walker; Kimberley A Jones; Madeleine J Patience; Zidan Zhao; Michael Nilsson
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study.

Authors:  Rajamannar Ramasubbu; Bradley G Goodyear
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

Review 9.  Post-stroke depression: mechanisms, translation and therapy.

Authors:  Isabelle Loubinoux; Golo Kronenberg; Matthias Endres; Pascale Schumann-Bard; Thomas Freret; Robert K Filipkowski; Leszek Kaczmarek; Aurel Popa-Wagner
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

Review 10.  The neurobiological pathogenesis of poststroke depression.

Authors:  Chao Feng; Min Fang; Xue-Yuan Liu
Journal:  ScientificWorldJournal       Date:  2014-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.